image:Compared with a control (left), treatment with SLR14 (right) reduces the signs of inflammation and pneumonia in the lungs of SARS-CoV-2infected mice. view more Credit: 2021 Mao et al
image:Compared with a control (left), treatment with SLR14 (right) reduces the signs of inflammation and pneumonia in the lungs of SARS-CoV-2infected mice. view more Credit: 2021 Mao et al
The study, published in the journalNatureand part-funded by the UK charity Worldwide Cancer Research, uncovers how palmitic acid alters the cancer genome, increasing the likelihood the cancer will spread. The researchers have started developing therapies that interrupt this process and say a clinical trial could start in the next couple of years. Metastasis or the spread of cancer remains the main cause of death in cancer patients and the vast majority of people with metastatic cancer can only be treated, but not cured.
Haarsma told me that the rise of the creationism movement in the 1960s, led by the engineer Henry Morris, increased the skepticism between some evangelical churches and scientists. The rift continued to grow because of bioethical conflicts around issues like stem cell research and euthanasia, but more so because of a latent cultural assumption that faith and fact oppose each other.
BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--EdiGene, Inc., a global biotechnology company focused on translating gene-editing technologies into transformative therapies for patients with serious genetic diseases and cancer, will present its latest research on a novel surface marker of human hematopoietic stem cells (HSCs) which could support long-term HSCs repopulation, and on microtubule polymerization inhibition that could enhance HSC homing and engraftment at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta on December 11-14, 2021. The research to be presented during the ASH meeting shows that CD66e is a robust functional HSC bio-marker that can support efficient long-term HSCs identification and repopulation
PHILADELPHIA, Nov.
DUARTE, Calif.--(BUSINESS WIRE)--City of Hope announced today that it will present new research on bispecific antibodies at a press briefing during the ASH 63rd Annual Meeting and Exposition on Dec. 11 to 14 in Atlanta. Other innovative City of Hope research on stem cell transplants and blood cancer treatments will also be presented during the conference organized by ASH.
Using a new mini-brain model, a large team of researchers were able to demonstrate the damaging changes that occur in brain cells of people with frontotemporal dementia (FTD). Published in Cell on Aug
Advances in three-dimensional organoid technology have revolutionized the stem cell field.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplants to more patients, today reported financial results for the third quarter ended September 30, 2021, and recent program highlights. We are pleased with our recent execution across the portfolio as we look to continue to allocate our capital efficiently to our value-creating opportunities, said Jason Gardner, D.Phil., President and Chief Executive Officer, Magenta Therapeutics.
Organoid technologies have become a powerful emerging tool to model liver diseases, for drug screening, and for personalized treatments. Assoc. Prof
Recent Comments